Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis
PASADENA, Calif., October 21, 2025–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that a global licensing and collaboration…